Omeros (OMER) | Financial Analysis & Statements
Omeros Corporation Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
0
Operating Income
-29.1M
Net Income
86.5M
EPS (Diluted)
$0.98
Balance Sheet Metrics
Total Assets
325.6M
Total Liabilities
446.9M
Shareholders Equity
-121.2M
Cash Flow Metrics
Operating Cash Flow
110.6M
Free Cash Flow
-39.8M
Revenue & Profitability Trend
Omeros Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | - | 0 | 0 |
| Cost of Goods Sold | - | - | - | - | 0 |
| Gross Profit | - | - | - | - | 0 |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 81.3M | 119.5M | - | 112.7M | 118.8M |
| Selling, General & Administrative | 41.5M | 49.7M | - | 50.7M | 54.8M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 122.8M | 169.3M | 0 | 163.4M | 173.6M |
| Operating Income | -122.8M | -169.3M | - | -163.4M | -173.6M |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 5.1M | 11.3M | - | 4.1M | 1.7M |
| Interest Expense | - | 24.7M | - | 22.7M | 19.7M |
| Other Non-Operating Income | 114.9M | - | - | - | 1.7M |
| Pre-tax Income | -2.8M | -182.6M | - | -182.0M | -191.5M |
| Income Tax | 2.0M | - | - | 0 | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -3.4M | -156.8M | - | 47.4M | 194.2M |
| Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Key Metrics | |||||
| EBITDA | -236.8M | -157.0M | - | -158.4M | -170.5M |
| EPS (Basic) | $-0.05 | $-2.70 | $-1.88 | $0.76 | $3.12 |
| EPS (Diluted) | $-0.05 | $-2.70 | $-1.88 | $0.76 | $3.12 |
| Basic Shares Outstanding | 63510201 | 58170931 | 62739227 | 62737091 | 62344100 |
| Diluted Shares Outstanding | 63510201 | 58170931 | 62739227 | 62737091 | 62344100 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Omeros Balance Sheet From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 9.7M | 3.4M | 11.0M | 100.8M | 10.5M |
| Short-term Investments | 162.1M | 86.7M | 183.9M | 56.5M | 124.5M |
| Accounts Receivable | 6.4M | 6.9M | 213.0M | 35.5M | 3.8M |
| Inventory | - | - | - | - | 1.4M |
| Other Current Assets | 7.6M | 7.2M | 6.3M | 8.2M | 10.5M |
| Total Current Assets | 215.7M | 134.1M | 443.2M | 248.0M | 151.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 22.8M | 27.0M | 9.3M | 9.1M | 8.6M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 97.5M | 125.3M | 124.5M | 141.3M | 1.1M |
| Total Non-Current Assets | 110.0M | 143.0M | 147.7M | 171.3M | 29.8M |
| Total Assets | 325.6M | 277.1M | 591.0M | 419.3M | 181.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 4.8M | 5.9M | 6.0M | 13.4M | 4.2M |
| Short-term Debt | 23.4M | 27.0M | 98.7M | 5.3M | 3.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 20.5M | 20.6M | 1.2M | - | - |
| Total Current Liabilities | 78.1M | 79.5M | 136.4M | 51.8M | 36.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 215.8M | 180.0M | 243.3M | 342.6M | 265.1M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 147.3M | 195.6M | 125.1M | - | - |
| Total Non-Current Liabilities | 368.8M | 380.2M | 368.9M | 343.7M | 265.1M |
| Total Liabilities | 446.9M | 459.7M | 505.3M | 395.5M | 301.8M |
| Equity | |||||
| Common Stock | 716.0K | 580.0K | 628.0K | 626.0K | 616.0K |
| Retained Earnings | -913.7M | -910.3M | -635.7M | -683.1M | -872.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -121.2M | -182.6M | 85.7M | 23.8M | -120.8M |
| Key Metrics | |||||
| Total Debt | 239.1M | 207.0M | 342.0M | 347.8M | 268.8M |
| Working Capital | 137.6M | 54.6M | 306.9M | 196.2M | 114.5M |
Balance Sheet Composition
Omeros Cash Flow Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -3.4M | -156.8M | 47.4M | 194.2M | -138.1M |
| Depreciation & Amortization | 964.0K | 950.0K | 952.0K | 1.4M | 1.6M |
| Stock-Based Compensation | 8.2M | 10.5M | 14.1M | 17.6M | 14.9M |
| Working Capital Changes | 30.4M | 40.0M | -109.6M | -19.0M | 11.4M |
| Operating Cash Flow | -877.0K | -134.2M | -76.8M | 195.9M | -110.5M |
| Investing Activities | |||||
| Capital Expenditures | 239.9M | -165.0K | -113.0K | -277.0K | -283.0K |
| Acquisitions | - | - | 0 | 126.0M | 0 |
| Investment Purchases | -185.3M | -987.4M | -429.0M | -32.0M | -133.2M |
| Investment Sales | 109.9M | 1.1B | 301.6M | 100.0M | 66.4M |
| Investing Cash Flow | 164.5M | 82.2M | -127.6M | 193.7M | -67.0M |
| Financing Activities | |||||
| Share Repurchases | 0 | -11.9M | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | 0 | 0 | 225.0M |
| Debt Repayment | -89.2M | -41.3M | -1.2M | -1.8M | -126.8M |
| Financing Cash Flow | -49.8M | 62.3M | 123.8M | -2.1M | 169.5M |
| Free Cash Flow | -116.2M | -149.0M | -86.6M | -110.0M | -100.4M |
| Net Change in Cash | 113.8M | 10.4M | -80.5M | 387.6M | -8.0M |
Cash Flow Trend
Omeros Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-270.50
Forward P/E
10.31
Price to Book
-7.90
PEG Ratio
0.83
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
2.76%
Return on Assets
-25.47%
Financial Health
Current Ratio
2.76
Debt to Equity
-2.06
Beta
2.53
Per Share Data
EPS (TTM)
$-0.08
Book Value per Share
$-1.69
Revenue per Share
$0.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| OMER | 973.4M | -270.50 | -7.90 | 2.76% | 0.00% | -2.06 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






